Recent changes in bacterial epidemiology and the emergence of fluoroquinolone-resistant Escherichia coli among patients with haematological malignancies: results of a prospective study on 823 patients at a single institution.
about
New Insight on Epidemiology and Management of Bacterial Bloodstream Infection in Patients with Hematological MalignanciesAntibacterial Resistance in Patients with Hematopoietic Stem Cell Transplantation.Risk Adapted Management of Febrile Neutrepenia and Early Cessation of Empirical Antibiotherapy in Hematopoietic Stem Cell Transplantation Setting.Randomized double blind trial of ciprofloxacin prophylaxis during induction treatment in childhood acute lymphoblastic leukemia in the WK-ALL protocol in Indonesia.Management of febrile neutropenia in the era of bacterial resistanceAmbulatory consolidation chemotherapy for acute myeloid leukemia with antibacterial prophylaxis is associated with frequent bacteremia and the emergence of fluoroquinolone resistant E. Coli.Long-term epidemiology of bacterial susceptibility profiles in adults suffering from febrile neutropenia with hematologic malignancy after antibiotic change.In vitro antimicrobial activity of ten medicinal plants against clinical isolates of oral cancer casesFluoroquinolone resistance in bacteremic and low risk febrile neutropenic patients with cancer.How to treat severe infections in critically ill neutropenic patients?Clinical and Microbiological Profile of Pathogens in Febrile Neutropenia in Hematological Malignancies: A Single Center Prospective Analysis.Causative Organisms and Associated Antimicrobial Resistance in Healthcare-Associated, Central Line-Associated Bloodstream Infections From Oncology Settings, 2009-2012.Prevalence of Resistant Gram-Negative Bacilli in Bloodstream Infection in Febrile Neutropenia Patients Undergoing Hematopoietic Stem Cell Transplantation: A Single Center Retrospective Cohort Study.Prophylaxis with levofloxacin: impact on bacterial susceptibility and epidemiology in a hematopoietic stem cell transplant unitAntibiotic management of febrile neutropenia: current developments and future directions.The strategy of antibiotic use in critically ill neutropenic patientsUsing antimicrobial adjuvant therapy in cancer treatment: a review.Review of clinical profile and bacterial spectrum and sensitivity patterns of pathogens in febrile neutropenic patients in hematological malignancies: A retrospective analysis from a single center.Escherichia coli: an important pathogen in patients with hematologic malignancies.Bloodstream infections in acute myeloid leukemia patients treated according to the Finnish Leukemia Group AML-2003 protocol - a prospective nationwide study.Antibiotic resistance is associated with longer bacteremic episodes and worse outcome in febrile neutropenic children with cancer.Comparison of antibiotic prophylaxis with cotrimoxazole/colistin (COT/COL) versus ciprofloxacin (CIP) in patients with acute myeloid leukemia.P. aeruginosa bloodstream infections among hematological patients: an old or new question?Infection profile of patients undergoing autologous bone marrow transplantation in a Brazilian institution.Empirical therapy with ceftazidime combined with levofloxacin or once-daily amikacin for febrile neutropenia in patients with neoplasia: a prospective comparative study.Use of antibacterial prophylaxis for patients with neutropenia. Australian Consensus Guidelines 2011 Steering Committee.Emerging resistant bacteria strains in bloodstream infections of acute leukaemia patients: results of a prospective study by the Rete Ematologica Lombarda (Rel).Etiology, clinical course and outcome of healthcare-associated bloodstream infections in patients with hematological malignancies: a retrospective study of 350 patients in a Finnish tertiary care hospital.Epidemiology and emerging resistance in bacterial bloodstream infections in patients with hematologic malignancies.Temporal interplay between efflux pumps and target mutations in development of antibiotic resistance in Escherichia coli.Bacteremia in Swedish hematological patients with febrile neutropenia: bacterial spectrum and antimicrobial resistance patterns.Recent increase in enterococci, viridans streptococci, Pseudomonas spp. and multiresistant strains among haematological patients, with a negative impact on outcome. Results of a 3-year surveillance study at a single institution.Epidemiology of bloodstream infections in patients with haematological malignancies with and without neutropenia.Incidence of fluoroquinolone-resistant and extended-spectrum β-lactamase-producing Escherichia coli at a comprehensive cancer center in the United States.Chlorhexidine for the prevention of bloodstream infection associated with totally implantable venous ports in patients with solid cancers.Relapsing bloodstream infections during treatment of acute leukemia.Effectiveness of antibacterial prophylaxis during induction chemotherapy in children with acute lymphoblastic leukemia.Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 Update by the Infectious Diseases Society of America.Audit of fluoroquinolone prophylaxis against chemotherapy-induced febrile neutropenia in a hospital with highly prevalent fluoroquinolone resistanceFluoroquinolone prophylaxis: a word of caution
P2860
Q26799580-DB1AB3FB-B35A-4E74-99AF-3ED80E8EC4FDQ30238945-D102E865-7612-4630-9300-F2D5FEF488E2Q33572014-44619209-B640-489E-81DA-4850F4AD0932Q34583481-B7BDCF56-2CCB-47D4-89FC-F5DE2C12C1E5Q34664160-1BC21BA7-F944-4DAD-86EB-CBE7E8B4654EQ34783463-5EEFBE0C-6326-49B4-A543-31A6A3C2E6BAQ35026599-92D55ABA-0688-46DE-8BF9-D4FAC0369C8EQ35063658-F359309B-059F-4B71-92A0-FED531D8E4FBQ35078855-DDD26767-EFE5-4AB0-BF40-A1692A99172DQ35457899-CF4494CD-BAF7-4698-B7F5-560677F66F22Q35935589-54608C1C-65C9-4FC9-BD96-5E0149403F4AQ36973200-8E2F63D1-0AD4-4A8A-90AA-851FB8CA7754Q37016637-398B7027-97BC-4932-813C-DD803AFD8019Q37628616-191E5492-C007-4A30-AE8E-36D4D0920A1AQ37708866-4A762CE5-A1B9-4E07-818E-2E7A309EBD1EQ37929895-4F9893E1-C35F-434E-AE2D-D2B8F369D68EQ38060894-A5F90F4B-B84D-4E61-9106-7F356730EC26Q38139377-44DF3DED-E82B-4DC1-89D7-0F8E68688486Q38269510-6232D92C-10B5-41E3-9796-C1E7047BF897Q38690746-A0689F38-B0BA-4504-B44B-46FF442A553DQ38988511-A4FAE84C-43C2-4B2F-869C-9BE8E08A3B5AQ40172700-A14DF226-DE91-454D-8B23-FADC76948D71Q40295711-9E82EA5C-3060-4B09-9A3C-7F1471117C32Q40295892-2114F108-0043-4558-B239-AACC21DB9125Q40307628-8EABBB15-675E-4538-8527-B3090D81FFB0Q40335974-DE367109-FCC4-4ACF-AE4D-17FDFBDC34B6Q40469049-22AE5A66-3230-4FF1-ACB0-5D20246130CCQ41153995-9E422E91-EB96-4128-AECF-7955366B58A7Q41195981-E41A9AEC-40C3-488C-86D1-D5193C9E8FD9Q41788804-65E7AA5B-D973-429A-831C-EAAEBA6BB007Q42288205-65B4D729-9D69-4720-BD60-BC5EEA4B7B2AQ43184611-532038F8-403A-4D80-BC25-19FDA411E98DQ43235040-D5F7FC72-4B54-4BC2-8195-58BB0F973797Q44035214-96228ED9-CF4C-409C-8859-7860B2BBF710Q44998054-593BD275-6797-40BD-AFED-7D9C4F38AA1BQ45355151-FCD460FB-7DEB-4066-99BD-66AA5ECEF388Q48272108-A0899833-3919-4716-AAA5-9BF9D11BECE7Q51617424-D45DCDDE-4E22-46D6-B732-12688CB9074FQ56791660-B094004F-E0F0-4527-AA05-F538E3643137Q57746203-2CBC59BF-5D9C-4CD8-8068-EF3CBA91DE6A
P2860
Recent changes in bacterial epidemiology and the emergence of fluoroquinolone-resistant Escherichia coli among patients with haematological malignancies: results of a prospective study on 823 patients at a single institution.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Recent changes in bacterial ep ...... ients at a single institution.
@en
type
label
Recent changes in bacterial ep ...... ients at a single institution.
@en
prefLabel
Recent changes in bacterial ep ...... ients at a single institution.
@en
P2093
P356
P1476
Recent changes in bacterial ep ...... tients at a single institution
@en
P2093
C Cattaneo
E Borlenghi
G Quaresmini
L Signorini
M A Capucci
M Micheletti
P304
P356
10.1093/JAC/DKM514
P407
P577
2008-01-24T00:00:00Z